Inspire Newsroom

Inspire collaborated with leading researchers to develop the SCIPPP-F questionnaire, a reliable tool assessing the sexual health of female partners of prostate cancer patients. Published in European Urology Oncology, the study highlights the impact of prostate cancer treatments on partners and underscores the importance of inclusive survivorship care.

Inspire, the leading online health community and real-world data platform, has appointed Brett Kleger as CEO, effective June 5, 2024. Kleger brings extensive leadership experience, previously driving growth at Datacubed Health and DrugDev. Known for transforming companies into market leaders, Kleger aims to accelerate Inspire’s growth in real-world evidence, clinical trial recruitment, and patient engagement solutions.

Inspire has announced that it will present new research at Digestive Disease Week (DDW) 2024, unveiling insights from a mixed-method study on Short Bowel Syndrome (SBS) patient experience.

At ISPOR 2024, Inspire researchers will present groundbreaking findings in chronic lymphocytic leukemia (CLL) management. By integrating patient voices from Inspire’s community with medical data, the study highlights key unmet needs and long-term complications in CLL care, showcasing the value of real-world patient-centered insights.

A new Inspire study presented at IgNS 2023 sheds light on the challenges faced by patients with Multifocal Motor Neuropathy (MMN) and Chronic Inflammatory Demyelinating Polyradiculoneuropathy (CIDP). In collaboration with Takeda Pharmaceuticals and leading experts, the study explores the patient journey, highlighting diagnostic challenges, treatment barriers, and unmet needs in education and care.

Inspire welcomes Laurel Netolicky and Michael Butterfield as Vice Presidents of Business Development. With extensive experience in digital marketing, advertising, and ad tech sales, both leaders bring expertise that will enhance Inspire’s client offerings, expand market reach, and drive growth while keeping patients at the center of healthcare innovation.